How can payers reduce drug cost burdens and prior authorization friction?

AJMC’s FAQ said payers can ease patient drug cost burdens by addressing silent nonadherence, reducing prior authorization burden, and improving confidence in biosimilars. The piece also pointed to PBM reform and supportive care needs, suggesting cost management should focus on lowering real-world friction for patients and physicians, not just unit price.